lobbying_activities: 3431742

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3431742	735bcc4d-53e8-4051-ae9e-5cb5ccedbe65	Q3	THE ALS ASSOCIATION	401104947	THE ALS ASSOCIATION	2025	third_quarter	PHA	H.R.1672 - Maintaining Investment in New Innovation Act - All Provisions H.R.1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program - Discussion around encouraging innovation and research transparency for rare disease drugs.	HOUSE OF REPRESENTATIVES,SENATE		30000	0	0	2025-10-14T11:04:18-04:00